Unknown

Dataset Information

0

Small-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory Axis.

ABSTRACT: TP53 is the most frequently mutated gene in human cancer, and small-molecule reactivation of mutant p53 function represents an important anticancer strategy. A cell-based, high-throughput small-molecule screen identified chetomin (CTM) as a mutant p53 R175H reactivator. CTM enabled p53 to transactivate target genes, restored MDM2 negative regulation, and selectively inhibited the growth of cancer cells harboring mutant p53 R175H in vitro and in vivo. We found that CTM binds to Hsp40 and increases the binding capacity of Hsp40 to the p53 R175H mutant protein, causing a potential conformational change to a wild-type-like p53. Thus, CTM acts as a specific reactivator of the p53 R175H mutant form through Hsp40. These results provide new insights into the mechanism of reactivation of this specific p53 mutant.

SUBMITTER: Hiraki M 

PROVIDER: S-EPMC4670040 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

TP53 is the most frequently mutated gene in human cancer, and small-molecule reactivation of mutant p53 function represents an important anticancer strategy. A cell-based, high-throughput small-molecule screen identified chetomin (CTM) as a mutant p53 R175H reactivator. CTM enabled p53 to transactivate target genes, restored MDM2 negative regulation, and selectively inhibited the growth of cancer cells harboring mutant p53 R175H in vitro and in vivo. We found that CTM binds to Hsp40 and increase  ...[more]

Similar Datasets

Unknown Small molecule induced reactivation of mutant p53 in cancer cells.
| S-EPMC3695503 | biostudies-literature
Unknown Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule.
| S-EPMC4826208 | biostudies-literature
Unknown A Small Molecule Reacts with the p53 Somatic Mutant Y220C to Rescue Wild-type Thermal Stability.
| S-EPMC9827106 | biostudies-literature
Unknown Follow the Mutations: Toward Class-Specific, Small-Molecule Reactivation of p53.
| S-EPMC7072143 | biostudies-literature
Unknown Allele-specific p53 mutant reactivation.
| S-EPMC3366694 | biostudies-literature
Unknown Wild-type p53 reactivation by small-molecule Minnelide™ in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma.
| S-EPMC4678773 | biostudies-other
Unknown Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway.
| S-EPMC2327210 | biostudies-literature
Unknown SCH529074, a small molecule activator of mutant p53, which binds p53 DNA binding domain (DBD), restores growth-suppressive function to mutant p53 and interrupts HDM2-mediated ubiquitination of wild type p53.
| S-EPMC2856225 | biostudies-literature
Unknown Therapeutic targeting of <i>BRCA1</i> and <i>TP53</i> mutant breast cancer through mutant p53 reactivation.
| S-EPMC6465291 | biostudies-literature
Unknown Retinal angiogenesis suppression through small molecule activation of p53.
| S-EPMC3784529 | biostudies-other